332 related articles for article (PubMed ID: 18849168)
21. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
[TBL] [Abstract][Full Text] [Related]
22. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5).
Bach P; Nilsson K; Svensson T; Bauer U; Hammerland LG; Peterson A; Wållberg A; Osterlund K; Karis D; Boije M; Wensbo D
Bioorg Med Chem Lett; 2006 Sep; 16(18):4788-91. PubMed ID: 16837196
[TBL] [Abstract][Full Text] [Related]
24. Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo.
Lindsley CW; Wisnoski DD; Leister WH; O'brien JA; Lemaire W; Williams DL; Burno M; Sur C; Kinney GG; Pettibone DJ; Tiller PR; Smith S; Duggan ME; Hartman GD; Conn PJ; Huff JR
J Med Chem; 2004 Nov; 47(24):5825-8. PubMed ID: 15537338
[TBL] [Abstract][Full Text] [Related]
25. A new series of pyridinyl-alkynes as antagonists of the metabotropic glutamate receptor 5 (mGluR5).
Bach P; Nilsson K; Wållberg A; Bauer U; Hammerland LG; Peterson A; Svensson T; Osterlund K; Karis D; Boije M; Wensbo D
Bioorg Med Chem Lett; 2006 Sep; 16(18):4792-5. PubMed ID: 16839764
[TBL] [Abstract][Full Text] [Related]
26. Arylmethoxypyridines as novel, potent and orally active mGlu5 receptor antagonists.
Büttelmann B; Peters JU; Ceccarelli S; Kolczewski S; Vieira E; Prinssen EP; Spooren W; Schuler F; Huwyler J; Porter RH; Jaeschke G
Bioorg Med Chem Lett; 2006 Apr; 16(7):1892-7. PubMed ID: 16439120
[TBL] [Abstract][Full Text] [Related]
27. New positive allosteric modulators of the metabotropic glutamate receptor 2 (mGluR2): identification and synthesis of N-propyl-8-chloro-6-substituted isoquinolones.
Trabanco AA; Duvey G; Cid JM; Macdonald GJ; Cluzeau P; Nhem V; Furnari R; Behaj N; Poulain G; Finn T; Lavreysen H; Poli S; Raux A; Thollon Y; Poirier N; D'Addona D; Andrés JI; Lutjens R; Le Poul E; Imogai H; Rocher JP
Bioorg Med Chem Lett; 2011 Feb; 21(3):971-6. PubMed ID: 21232953
[TBL] [Abstract][Full Text] [Related]
28. Discovery of imidazo[1,2-a]pyridines as potent MCH1R antagonists.
Kishino H; Moriya M; Sakuraba S; Sakamoto T; Takahashi H; Suzuki T; Moriya R; Ito M; Iwaasa H; Takenaga N; Ishihara A; Kanatani A; Sato N; Fukami T
Bioorg Med Chem Lett; 2009 Aug; 19(16):4589-93. PubMed ID: 19615899
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and structure-activity relationships of thieno[2,3-b]pyridin-4-one derivatives as a novel class of potent, orally active, non-peptide luteinizing hormone-releasing hormone receptor antagonists.
Imada T; Cho N; Imaeda T; Hayase Y; Sasaki S; Kasai S; Harada M; Matsumoto H; Endo S; Suzuki N; Furuya S
J Med Chem; 2006 Jun; 49(13):3809-25. PubMed ID: 16789738
[TBL] [Abstract][Full Text] [Related]
30. Dipyridyl amides: potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists.
Bonnefous C; Vernier JM; Hutchinson JH; Chung J; Reyes-Manalo G; Kamenecka T
Bioorg Med Chem Lett; 2005 Feb; 15(4):1197-200. PubMed ID: 15686941
[TBL] [Abstract][Full Text] [Related]
31. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships of 2-acylamino-4,6-diphenylpyridine derivatives as novel antagonists of GPR54.
Kobayashi T; Sasaki S; Tomita N; Fukui S; Kuroda N; Nakayama M; Kiba A; Takatsu Y; Ohtaki T; Itoh F; Baba A
Bioorg Med Chem; 2010 Jun; 18(11):3841-59. PubMed ID: 20457527
[TBL] [Abstract][Full Text] [Related]
33. Identification of a novel transmembrane domain involved in the negative modulation of mGluR1 using a newly discovered allosteric mGluR1 antagonist, 3-cyclohexyl-5-fluoro-6-methyl-7-(2-morpholin-4-ylethoxy)-4H-chromen-4-one.
Fukuda J; Suzuki G; Kimura T; Nagatomi Y; Ito S; Kawamoto H; Ozaki S; Ohta H
Neuropharmacology; 2009 Sep; 57(4):438-45. PubMed ID: 19559036
[TBL] [Abstract][Full Text] [Related]
34. Discovery of N-(5,6-diarylpyridin-2-yl)amide derivatives as potent and selective A(2B) adenosine receptor antagonists.
Eastwood P; Gonzalez J; Paredes S; Nueda A; Domenech T; Alberti J; Vidal B
Bioorg Med Chem Lett; 2010 Mar; 20(5):1697-700. PubMed ID: 20137946
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists.
Hoffmann T; Bös M; Stadler H; Schnider P; Hunkeler W; Godel T; Galley G; Ballard TM; Higgins GA; Poli SM; Sleight AJ
Bioorg Med Chem Lett; 2006 Mar; 16(5):1362-5. PubMed ID: 16332435
[TBL] [Abstract][Full Text] [Related]
36. 3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 3: Synthesis, metabolic stability, and biological evaluation of optically active analogs.
Asada M; Obitsu T; Kinoshita A; Nagase T; Yoshida T; Yamaura Y; Takizawa H; Yoshikawa K; Sato K; Narita M; Nakai H; Toda M; Tobe Y
Bioorg Med Chem; 2010 May; 18(9):3212-23. PubMed ID: 20385498
[TBL] [Abstract][Full Text] [Related]
37. In vitro pharmacological characterization of novel isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
Suzuki G; Tsukamoto N; Fushiki H; Kawagishi A; Nakamura M; Kurihara H; Mitsuya M; Ohkubo M; Ohta H
J Pharmacol Exp Ther; 2007 Oct; 323(1):147-56. PubMed ID: 17609420
[TBL] [Abstract][Full Text] [Related]
38. Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists.
Zheng GZ; Bhatia P; Kolasa T; Patel M; El Kouhen OF; Chang R; Uchic ME; Miller L; Baker S; Lehto SG; Honore P; Wetter JM; Marsh KC; Moreland RB; Brioni JD; Stewart AO
Bioorg Med Chem Lett; 2006 Sep; 16(18):4936-40. PubMed ID: 16809035
[TBL] [Abstract][Full Text] [Related]
39. (+)-(2R,5S)-4-[4-cyano-3-(trifluoromethyl)phenyl]-2,5-dimethyl-N-[6-(trifluoromethyl)pyridin-3- yl]piperazine-1-carboxamide (YM580) as an orally potent and peripherally selective nonsteroidal androgen receptor antagonist.
Kinoyama I; Taniguchi N; Toyoshima A; Nozawa E; Kamikubo T; Imamura M; Matsuhisa A; Samizu K; Kawanimani E; Niimi T; Hamada N; Koutoku H; Furutani T; Kudoh M; Okada M; Ohta M; Tsukamoto S
J Med Chem; 2006 Jan; 49(2):716-26. PubMed ID: 16420057
[TBL] [Abstract][Full Text] [Related]
40. Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
Nakamura M; Kurihara H; Suzuki G; Mitsuya M; Ohkubo M; Ohta H
Bioorg Med Chem Lett; 2010 Jan; 20(2):726-9. PubMed ID: 20005101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
